SMAD3 and breast cancer: This causes the inhibition of SMAD3 targeting and degradation by miR-140, resulting in amplified TGF-β1/SMAD3 signaling and miR-140 downregulation-dependent myofibroblast differentiation, with an impact on the stemness and proliferation of normal ductal epithelial cells in early-stage of BC invasion.